The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Synergistic Therapy
In article number 2101155, Yujun Song, Zhengbao Zha, Xin Han, and co‐workers report a novel thermo‐responsive nanotherapeutic platform, which is triggered by 808 nm near‐infrared light irradiation. This exogenously controlled method can be used in combination tumor therapy, including gene‐therapy, mild‐photothermal therapy, and chemotherapy, which provides a versatile strategy...
Manipulation of CRISPR delivery for stimuli‐responsive gene editing is crucial for cancer therapeutics through maximizing efficacy and minimizing side‐effects. However, realizing controlled gene editing for synergistic combination therapy remains a key challenge. Here, a near‐infrared (NIR) light‐triggered thermo‐responsive copper sulfide (CuS) multifunctional nanotherapeutic platform is constructed...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.